Literature DB >> 1861869

N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.

W H Brondyk1, F A Boeckman, W E Fahl.   

Abstract

The N-myc gene is amplified in several types of human tumors. To assess the role of the N-myc gene in the transformation of normal human cells, we transfected an N-myc expression vector into diploid human fibroblasts. Transfected clones were isolated and found to express the N-myc gene at levels similar to those seen in a tumor cell line (neuroblastoma LA-N-1) which contains an amplified N-myc gene. The level of N-myc expression decreased as the N-myc clones senesced. Clones expressing N-myc had an increased saturation density and an altered morphology but did not have an extended lifespan. Under low serum conditions, neither the clones expressing N-myc nor the control cells showed anchorage-dependent growth. Clones expressing N-myc were compared to control cells to determine if different growth factors would affect the ability of cells to grow in soft agarose. Clones expressing N-myc and the control cells did not grow in soft agarose supplemented with epidermal growth factor (EGF) or transforming growth factor-alpha (TGF-alpha). However, compared to control cells, clones expressing N-myc grew in agarose 2.8- to 18-fold higher in response to basic fibroblast growth factor (bFGF) and 5.5- to 55-fold higher in response to platelet-derived growth factor B-chain homodimer (PDGF-BB).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1861869

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Periodic fluctuations in proliferation of SV-40 transformed human skin fibroblast lines with prolonged lifespan.

Authors:  C Wolfrom; N Raynaud; J Maigne; S Papathanassiou; M Conti; N Kadhom; B Hecquet; F Levi; M Gautier; J Deschatrette
Journal:  Cell Biol Toxicol       Date:  1994-08       Impact factor: 6.691

2.  Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines.

Authors:  R Jasty; C van Golen; H J Lin; G Solomon; K Heidelberger; P Polverini; A Opipari; E Feldman; V P Castle
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

3.  MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.

Authors:  O B Chernova; M V Chernov; Y Ishizaka; M L Agarwal; G R Stark
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

4.  Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.

Authors:  V P Castle; K P Heidelberger; J Bromberg; X Ou; M Dole; G Nuñez
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

5.  Fructose-induced enhanced mitogenicity of diploid human cells: possible relationship with cell differentiation.

Authors:  C Wolfrom; N Kadhom; J Raulin; N Raynaud; M Gautier
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-04       Impact factor: 2.416

6.  Insulin-like growth factor II in the pathogenesis of human neuroblastoma.

Authors:  K A Sullivan; V P Castle; S M Hanash; E L Feldman
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.